Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Ekf Diagnostics Holdings Plc LSE:EKF London Ordinary Share GB0031509804 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 32.00 31.30 33.90 - 3,801 08:08:25
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 81.8 21.4 3.5 9.2 146

Ekf Diagnostics Share Discussion Threads

Showing 3226 to 3246 of 4425 messages
Chat Pages: Latest  141  140  139  138  137  136  135  134  133  132  131  130  Older
DateSubjectAuthorDiscuss
30/3/2021
07:26
Excellent, update as highlighted by rivaldo.
hastings
30/3/2021
07:23
In Hemetology, this news is significant, as anyone who seeks to get onto Tender Frameworks will know: EKF Link will enable us to enter all tenders moving forward that require connectivity which is a significant boost for the Company's commercial appeal.
faz
30/3/2021
07:19
Wow - if Carling did trading updates..... "the Board is confident that trading for the year ending 31 December 2021 will be significantly ahead of already upgraded management expectations" Plus the Covid-19 test kit contract has become "a new multi-million dollar global supply contract" which will secure large revenues through to essentially mid-2023 and then monthly after that. And it's now global rather than just the UK. Lovely stuff: Https://uk.advfn.com/stock-market/london/ekf-diagnostics-EKF/share-news/EKF-Diagnostics-Holdings-PLC-Trading-update-Expa/84696446
rivaldo
30/3/2021
05:26
Mirandaj...I am very familiar with that list. Due in part to a particular company from that list being on my doorstep (literally!) and operating from a dwellinghouse as a 'drive through test centre', best described in my book as a tinpot operation, despite the guise of a relatively slick website. Currently (and ongoing), Planning Enforcement think that "due the pandemic" it's unlikely that planning permission is required, which I think is of dubious legality for a property that according to the the Town and Country Planning Act 1990, and its current planning permission, is a class C3 Dwellinghouse and not remotely anything like a drive-through testing operation! Not to mention that such test to release companies effectively self-certify to become authorised. And like the Panorama programme last night, one has to ask who is checking what with regard to the standards of testing being delivered? From what I can tell, a certain company on that list is not actually authorised to conduct point-of-care testing, despite offering and undertaking such testing (rapid lateral flow antigen testing), and defined by the government and indeed UKAS as meeting the minimum standards (currently a self-declaration process), - Providers, including those for ‘Testing to Release for International Travel’ must self-declare that their service meets minimum standards through the gov.uk self-declaration process. This includes the requirement for test providers to at least be a UKAS applicant for the relevant international standard – ISO 15189 or ISO/IEC 17025 for lab-based providers and ISO 15189 and ISO 22870 for point of care testing providers. hTTps://www.ukas.com/resources/latest-news/government-announces-minimum-standards-for-covid-19-testing/ Some companies appear to be utilising their 'partner' labs for being compliant for laboratory tests (e.g. PCR tests sent off to those labs) but the sample collection is as important as the test result itself! But there is no evidence that at least one company on that list is meeting ISO 15189 and ISO 22870 that's required for conducting point-of-care testing, despite carrying out such tests. The government has put into place and enabled huge testing capacity, but if anyone watched Panorama last night, and given also that test to release operators can self-certify, we have to start asking some important and probing questions as to what the taxpayer and paying individuals are actually getting for their money, and whether those test results can actually be relied upon? Panorama 7:30pm 29 Mar 2021 Undercover: Inside the Covid Testing Lab hTTps://www.bbc.co.uk/iplayer/episode/m000tqjj/panorama-undercover-inside-the-covid-testing-lab Clearly, EKF and its partners do not resemble what I am seeing, or watching on TV last night! So, there could be an even larger slice of testing available to those able to actually deliver the appropriate quality and standards.
wan
29/3/2021
17:41
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/973999/covid-private-testing-providers-test-to-release-290321.csv/preview For interest
mirandaj
26/3/2021
16:39
I note that EKF gets some good coverage in Moneyweek this week - Scientific-instrument companies are a global success – here's how to play them Companies delivering scientific instruments – products to measure and analyse our world – are crucial to sectors ranging from telecommunications to pharmaceuticals. Dr Mike Tubbs picks his favourite stocks in the sector. by: Dr Mike Tubbs 26 MAR 2021 Full story (part story if not a subscriber) - hTTps://moneyweek.com/investments/stocks-and-shares/share-tips/602992/scientific-instrument-companies-are-a-global Also mentioned in the IC re favourite investment in ESG Fund
wan
24/3/2021
16:47
Polar Technology Trust were one of the 5 presenters on AJ Bell's ISA suggestion webcast yesterday. OPM Ben Rogoff cited telemedicine as one area of great interest and one of their key bottom down themes. He mentioned Teladoc TDOC (probably best known, m cap $30bn) Amwell AMWL(MC $4.5bn)and Babylon, a UK-based company reportedly seeking a listing, possibly in the US. Anyway, this is just further evidence that PMs are very interested in telemedicine which is obviously growing very rapidly but as usual there will be winners and losers. Although slghtly different a glance at the Cambridge Cognition figures this week suggested they are beginning to gain traction. Rogoff cited one estimate that the US alone could save $300bn pa in health costs through effective digitalisation/telemedicine. I know Trellus is very early stage and specialised but it does seem to be an area with excellent prospects if the execution is effective.
srichardson8
24/3/2021
07:49
Staying with long term, tremendous investment opportunities. EKF may be holding serval keys that enable entry to digital front doors - Katie Adams - Friday, February 26th, 2021 Below, seven executives from hospitals and health systems across the country discuss the importance of their organization's digital front door and what strategies went into the building of their websites. A hospital's digital front door is an essential part of its strategy to engage patients throughout each point of their healthcare journey using technology they have already integrated into their everyday lives. Full story - hTTps://www.beckershospitalreview.com/digital-marketing/why-hospitals-need-strong-digital-front-doors-7-execs-weigh-in.html
wan
23/3/2021
18:31
And what a surprise it wasn't that he was wan.
faz
23/3/2021
15:18
To be clear, Chris Mills has been the Non-Executive Chairman of EKF since April 2016. Also to be clear, as per my post above, he was not appointed a director of Trellus Health until yesterday.
wan
23/3/2021
14:54
Yes Buster so that if you wanted you could find out something about the Chairman of EKF and now director of trellis. What;s he been doing since November?
faz
23/3/2021
12:47
From 17th November 2020
busterdog2
23/3/2021
10:04
What a surprise - Chris Mills, https://www.voxmarkets.co.uk/articles/christopher-mills-the-uk-s-best-performing-small-cap-fund-manager-on-the-stocks-he-likes-a063393/
faz
23/3/2021
09:24
Briefly, I note that recently two new directors have been appointed in Trellus Health. Chris Mills (of Harwood capital) was appointed a director in Trellus Health yesterday. And a few days earlier Daniel Mahony (Co-head of Healthcare Polar Capital Global Healthcare Trust)
wan
22/3/2021
16:30
No brainer?
busterdog2
20/3/2021
09:32
I think you may have meant EKF under-promise and over-deliver, time will tell, but lets not try and second guess too much at this stage!
wan
20/3/2021
08:59
Totally agree Wan EKF do like to over deliver Renalytix and Vericci are worth a chunk of money too. I'm more intrigued as to the performance of the underlying business which appears to be strong. AIMHO GLA BTG
btgman
20/3/2021
08:28
It's hard to decipher much from daily share price movements..........until you can look backwards and see whether it was the start of a trend (hindsight)! Hence, I don't get hung up on analysing daily share price movements to support my investment rationale, but everyone to their own though. I am far more interested in the following excerpt from the recent RNS on the 10th March - "The Company's net cash at 31 December 2020 was in excess of GBP21m (as announced in the trading update of 12 January 2021). The Company therefore remains very well capitalised to execute its plans and continues to generate strong operating and net cashflows. As previously announced, the Company expects to pay a dividend again in December 2021 and expects to implement a progressive dividend policy." So, and as I mentioned previously, as of the 10th March, EKF "continues" to generate strong operating and net cashflows. And I thus look forward to the Results Presentation a week next Tuesday, with an early indication that the first quarter of the new financial year has started very well.
wan
20/3/2021
07:53
First sensible thing i hear on this board for ages. Well done for having a stop in place. Managing risk is the only factor under your control with Mr Market being in charge of returns. And yes I agree - as of now, the picture is still very hazy indeed (hence I am flat).
tongosti
19/3/2021
22:14
Yeah but that's "if" that happens. I have a stop in the market and other than that everything else including opinions here are irrelevant
davr0s
19/3/2021
18:57
Considering Mr Market is not making you happy, I am inclined to make you so - whatever you say chap ...Hope this helps?
tongosti
Chat Pages: Latest  141  140  139  138  137  136  135  134  133  132  131  130  Older
ADVFN Advertorial
Your Recent History
LSE
EKF
Ekf Diagno..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220701 09:00:39